Evotec SE (EVOTF)
OTCMKTS · Delayed Price · Currency is USD
8.52
-0.06 (-0.75%)
At close: Jul 18, 2025
Nordstrom Revenue
Evotec SE had revenue of 199.98M EUR in the quarter ending March 31, 2025, a decrease of -4.19%. This brings the company's revenue in the last twelve months to 788.22M, up 1.50% year-over-year. In the year 2024, Evotec SE had annual revenue of 796.97M with 1.99% growth.
Revenue (ttm)
788.22M EUR
Revenue Growth
+1.50%
P/S Ratio
1.67
Revenue / Employee
166.29K EUR
Employees
4,740
Market Cap
1.43B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 796.97M | 15.54M | 1.99% |
Dec 31, 2023 | 781.43M | 29.98M | 3.99% |
Dec 31, 2022 | 751.45M | 133.41M | 21.59% |
Dec 31, 2021 | 618.03M | 117.11M | 23.38% |
Dec 31, 2020 | 500.92M | 54.49M | 12.20% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
Evotec SE News
- 4 days ago - Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site - Accesswire
- 4 days ago - Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site - Accesswire
- 10 days ago - Evotec: Recovery Seems To Be Beginning - Seeking Alpha
- 12 days ago - Evotec, Webull And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
- 12 days ago - Evotec, Webull And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
- 12 days ago - Evotec lowers FY25 revenue forecast, keeps profit targets & confirms long-term 2028 outlook - Seeking Alpha
- 12 days ago - Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix - Accesswire
- 12 days ago - Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance - Accesswire